8-124504322-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_032026.4(TATDN1):c.542A>G(p.Glu181Gly) variant causes a missense change. The variant allele was found at a frequency of 0.0000864 in 1,607,876 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032026.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152164Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000844 AC: 21AN: 248754Hom.: 0 AF XY: 0.0000818 AC XY: 11AN XY: 134438
GnomAD4 exome AF: 0.0000907 AC: 132AN: 1455712Hom.: 0 Cov.: 29 AF XY: 0.0000884 AC XY: 64AN XY: 723850
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152164Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74334
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.542A>G (p.E181G) alteration is located in exon 9 (coding exon 9) of the TATDN1 gene. This alteration results from a A to G substitution at nucleotide position 542, causing the glutamic acid (E) at amino acid position 181 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at